Rey E, Duperron L, Gauthier R, Lemay M, Grignon A, LeLorier J
Am J Obstet Gynecol. 1985 Oct 1;153(3):311-2. doi: 10.1016/s0002-9378(85)80120-4.
The role that the new antiarrhythmic agents, such as verapamil and amiodarone, might play in the therapeutic strategy of tachycardia-induced fetal heart failure remains to be determined.
新型抗心律失常药物,如维拉帕米和胺碘酮,在心动过速诱发的胎儿心力衰竭治疗策略中可能发挥的作用仍有待确定。